首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Healthcare policy

缩写:

ISSN:1715-6572

e-ISSN:1715-6580

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引649
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ashley J Stevens Ashley J Stevens
This paper reviews the response by public sector research organizations and their technology transfer offices to the COVID-19 pandemic. It shows that leading universities and technology transfer associations quickly enacted licensing princi...
Matthew Herder,E Richard Gold,Srinivas Murthy Matthew Herder
Publicly funded research has contributed enormously to many products that were developed in the face of the COVID-19 pandemic. Yet universities' technology transfer practices have failed to ensure that these products are available in low- a...
Jason M Sutherland Jason M Sutherland
The spring has ushered in an unexpected number of major health policy announcements compared with the last 10 years. They are led by the federal government's outlines of a national pharmacare program, an unexpected dental care program (Prim...
Melanie McPhail,Christopher McCabe,Dean A Regier et al. Melanie McPhail et al.
Regulatory and reimbursement decisions for drugs and vaccines are increasingly based on limited safety and efficacy evidence. In this environment, life-cycle approaches to evaluation are needed. A life-cycle approach grants market approval ...
Aidan Bodner,Sarah Spencer,M Ruth Lavergne et al. Aidan Bodner et al.
Background: Private payment within primary care has not received extensive scrutiny, despite the emergence of "concierge" primary care services. Objective...
Jacqueline Limoges,Jesse Mclean,Daniel Anzola et al. Jacqueline Limoges et al.
Background: Notably higher rates of mental health issues have been reported among healthcare providers (HCPs) during the COVID-19 pandemic. Concerns over the impact of policy decisions on the well-being of HCPs is growing...
Joel Lexchin Joel Lexchin
Starting in 2017, retroactive to 2016, Innovative Medicines Canada (IMC) - the lobby group representing most of the large research-based pharmaceutical companies operating in Canada - initiated a voluntary system for companies to annually r...
Tara Kiran,Amy Craig-Neil,Paul Das et al. Tara Kiran et al.
Among those visiting a testing centre in Toronto, ON, between March and April 2020, people experiencing homelessness (n = 214) were more likely to test positive for COVID-19 compared with those not experiencing homelessness (n = 1,836) even...
Quinn Grundy Quinn Grundy
Declining public trust in government and expert advice is a public health priority, given its impact on vaccination uptake, adherence to guidelines and social cohesion. In the context of the COVID-19 Vaccine Task Force, conflicts of interes...
Joel Lexchin Joel Lexchin
Early in the COVID-19 pandemic, the federal government established a COVID-19 Vaccine Task Force to provide it with recommendations on a wide variety of issues related to vaccines. This article explores how the conflicts of interest of the ...